
Cisteen 50mg Infusion
Marketer
Vhb Life Sciences Inc
Salt Composition
Cisplatin (50mg)
Overview Cisteen 50mg Infusion
Cysteinate 50mg intravenous infusion is a prescription medication indicated for treating ovarian, cervical, and testicular cancers. Its mechanism of action involves inhibiting or retarding cancerous cell proliferation. Administration is via intravenous injection by a healthcare professional. Dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits might not be evident for several weeks or months; discontinue only under medical supervision. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and emesis. Ototoxicity (hearing impairment or damage) is a serious potential adverse reaction; pre- and ongoing hearing assessments are often employed. The medication may suppress blood cell counts (leukopenia and anemia), increasing infection risk. Regular blood work monitoring, including hematologic, hepatic, and renal function tests, is necessary. Prior to initiating treatment, disclose any history of renal impairment, as the medication can compromise kidney function. Interactions with other medications are possible; inform your healthcare provider of all concurrent medications. Use during pregnancy or lactation is contraindicated. Male infertility is a potential consequence; pre-treatment sperm banking should be considered.
Uses of Cisteen 50mg Infusion
Cancers affecting the ovaries, cervix, and testes.
Major Benefits of Cisteen 50mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cisteen 50mg Infusion:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Cisteen 50mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cisteen 50mg Infusion works:
Cisteen 50mg infusion is a cancer therapeutic agent. Its mechanism of action involves disrupting the genetic integrity (DNA and RNA) of malignant cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cisteen 50mg Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering 50mg Cisteen infusions is contraindicated during gestation due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Cisteen 50mg Infusion while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Cisteen 50mg Infusion may induce adverse reactions, potentially impairing driving capabilities. These reactions can include drowsiness and/or nausea, impacting the ability to operate a vehicle safely.
KidneyCAUTION
Patients with kidney impairment should use Cisteen 50mg Infusion cautiously, potentially requiring dosage modification. Consult a physician before use. Cisteen 50mg Infusion is contraindicated in those with severe kidney disease.
LiverSAFE IF PRESCRIBED
Cisteen 50mg Infusion appears safe for individuals with hepatic impairment. Available evidence indicates that dosage modification may not be necessary for this patient population. Physician consultation is recommended.
What if you forget to take Cisteen 50mg Infusion :
Should you inadvertently omit a dose of Cisteen 50mg Infusion, seek advice from your physician.
Facts to Know About Cisteen 50mg Infusion
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavioral Class | Platinum-based Anticancer Agents |
